AGE20s JERICHO ROSE TONE ESSENTIAL UV PRIMER GREEN MINT
- Manufacturer
- Aekyung Industrial Co., Ltd.
- Effective date
- 2020-06-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:24:45
Label at a glance#
ProductAGE20s JERICHO ROSE TONE ESSENTIAL UV PRIMER GREEN MINT
Active ingredientTITANIUM DIOXIDE, OCTINOXATE
Label structure1 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- AGE20s JERICHO ROSE TONE ESSENTIAL UV PRIMER GREEN MINT
- Ethylhexyl Methoxycinnamate, Titanium Dioxide
- TRIETHOXYCAPRYLYLSILANE
- SILICON DIOXIDE
- MACROCYSTIS PYRIFERA
- TOCOPHEROL
- BUTYLENE GLYCOL
- DIMETHICONE
- TITANIUM DIOXIDE
- CYCLOMETHICONE 6
- GLYCERIN
- METHYL METHACRYLATE/GLYCOL DIMETHACRYLATE CROSSPOLYMER
- VINYL DIMETHICONE/METHICONE SILSESQUIOXANE CROSSPOLYMER
- MICA
- PANTHENOL
- P-ANISIC ACID
- DISTEARDIMONIUM HECTORITE
- ROSA CENTIFOLIA FLOWER
- BUTYLENE GLYCOL DICAPRYLATE/DICAPRATE
- OCTINOXATE
- ISODECYL NEOPENTANOATE
- POLYMETHYLSILSESQUIOXANE (4.5 MICRONS)
- ADENOSINE
- EDETATE DISODIUM
- KAKADU PLUM
- GLYCERYL CAPRYLATE
- 1,2-HEXANEDIOL
- SELAGINELLA LEPIDOPHYLLA
- APPLE
- CETYL PEG/PPG-10/1 DIMETHICONE (HLB 2)
- PENTYLENE GLYCOL
- HYALURONIC ACID
- PROPYLENE CARBONATE
- METHICONE (20 CST)
- ALUMINUM HYDROXIDE
- POLYGLYCERYL-3 POLYDIMETHYLSILOXYETHYL DIMETHICONE (4000 MPA.S)
- NIACINAMIDE
- DIPROPYLENE GLYCOL
- PHENOXYETHANOL
- .ALPHA.-TOCOPHEROL ACETATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 67225-5610 | 67225-5610-1 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| dec84ad0-4ae5-29d7-e053-2a95a90a7449 | a239b530-98de-543c-e053-2a95a90aae11 | 2022-05-11 | a239b530-98de-543c-e053-2a95a90aae11 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
